An emerging understanding of the Janus face of the human microbiome: enhancement versus impairment of cancer therapy

Nucleoside-catabolizing Enzymes in Mycoplasma-infected Tumor Cell Cultures Compromise the Cytostatic Activity of the Anticancer Drug Gemcitabine

(2014) Johan Vande Voorde et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment

(2013) N. Iida et al.   SCIENCE

The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide

(2013) S. Viaud et al.   SCIENCE

Bacteria and tumours: causative agents or opportunistic inhabitants?

(2013) Joanne Cummins et al.   Infectious Agents and Cancer

TAS-102 monotherapy for pretreated metastatic colorectal cancer: a double-blind, randomised, placebo-controlled phase 2 trial

(2012) Takayuki Yoshino et al.   LANCET ONCOLOGY

Tumour Targeting with Systemically Administered Bacteria

(2010) David Morrissey et al.   CURRENT GENE THERAPY

Enzymology of Purine and Pyrimidine Antimetabolites Used in the Treatment of Cancer

(2009) William B. Parker   CHEMICAL REVIEWS

Improvement of purine and pyrimidine antimetabolite-based anticancer treatment by selective suppression of mycoplasma-encoded catabolic enzymes

(2009) Sandra Liekens et al.   LANCET ONCOLOGY